48145
2015-16
364
Pharmaceutical Pricing Regulation Scheme
Greg Mulholland
2015-07-21
That this House notes the Pharmaceutical Pricing Regulation Scheme (PPRS), a voluntary scheme where drugs companies pay a rebate to the Department of Health when NHS spending on branded medicines goes above agreed growth rates; further notes that the PPRS payment estimate for the UK in 2014-15 is £443 million and in 2015-16 is £995 million, of which the revised estimates of PPRS payments subsequently allocated to NHS England are £363 million and £796 million for those years respectively; shares industry concern that it is not clear where exactly these funds go once they have been allocated to the devolved health administrations; believes rebates from drugs companies should be properly accounted for and be used for spending on drugs; and therefore calls on the Department of Health to ringfence PPRS payments specifically to pay for drugs, in order to ensure patients elsewhere in the UK can also get access to much-needed treatments as soon as possible.
Health finance
Health services
Medicine
Greg Mulholland
2015-07-21
Proposed
Leeds North West
Liberal Democrat
Mark Durkan
2015-09-07
Seconded
Foyle
Social Democratic and Labour Party
Jim Shannon
2015-09-07
Seconded
Strangford
DUP
Margaret Ritchie
2015-09-08
Seconded
South Down
Social Democratic and Labour Party
David Simpson
2015-09-09
Seconded
Upper Bann
DUP
Jeremy Corbyn
2015-09-10
Seconded
Islington North
Labour
Jim Cunningham
2015-09-10
Signed
Coventry South
Labour
Roger Godsiff
2015-09-11
Signed
Birmingham, Hall Green
Labour
Rachael Maskell
2015-09-14
Signed
York Central
Labour/Co-operative
Paul Flynn
2015-09-15
Signed
Newport West
Labour
Yasmin Qureshi
2015-10-26
Signed
Bolton South East
Labour